Clorox Earnings Call: Innovation, ERP Wins, Margin Hopes

Clorox Company ((CLX)) has held its Q2 earnings call. Read on for the main highlights of the call.

Clorox Balances Cautious Optimism With Persistent Category Headwinds

Clorox’s latest earnings call struck a tone of cautious optimism, with management emphasizing solid execution progress on its ERP rollout, digital capabilities, and a heavy back-half innovation slate, even as it grappled with weak category growth, household segment pressure, and an aggressive promotional environment. Leadership reaffirmed full-year guidance, pointed to early signs of improvement and Q4 margin recovery, but made clear that a more meaningful earnings rebound will depend on innovation landing well at retail and a pickup in category demand from today’s muted levels.

ERP Implementation Nearing the Finish Line

Clorox confirmed that the final phase of its enterprise resource planning (ERP) implementation was completed in January, marking the end of a multi-year systems upgrade that had been a source of operational noise. The final-phase manufacturing and retail prebuild boosted Q2 shipments by about 1 percentage point, a benefit that will reverse in Q3 and add short-term volatility to reported sales. Management expects remaining one-time digital and ERP-related adjustments in Q3 to weigh roughly $0.08 per share but believes the system will become an earnings tailwind longer term. As phasing normalizes, they see shipment normalization adding around 3.5 points of sales and driving an estimated EPS uplift of about $0.90 in the next fiscal year, positioning ERP as a key margin and growth enabler rather than a drag.

Back-Half Innovation Pipeline and Bigger Launch Bets

A core pillar of Clorox’s back-half strategy is a dense innovation pipeline across its flagship brands, supported by noticeably higher investment behind launches. The company highlighted new products such as an allergen-destroying cleaner, Glad Leakguard trash bags, a broad relaunch of its cat litter portfolio, an avocado ranch extension under Hidden Valley, and the expansion of Glad’s four-flex platform. Management said it has roughly doubled the typical marketing outlay for select priority launches to ensure strong trial and visibility. Most shelf resets tied to these innovations are expected in late Q3 and early Q4, meaning the earnings impact will be back-end loaded and could be a critical swing factor for both share and margin trajectory.

Strategic Health & Hygiene Push With Gojo/Purell

Clorox underscored the strategic importance of its planned acquisition of Gojo, the maker of Purell, in expanding its presence in health and hygiene. Management framed the deal as a strong fit that should enhance Clorox’s leadership in cleaning and disinfection, while tapping Gojo’s capabilities and operations to support growth in both professional and retail channels. The combination is expected to be accretive to growth over time and to unlock new avenues in high-value health and hygiene segments, reinforcing Clorox’s long-term positioning beyond its traditional household categories.

Digital and Revenue Growth Management to Sharpen Pricing

With ERP and data harmonization largely in place, Clorox is leaning into enhanced digital and Revenue Growth Management (RGM) tools to better fine-tune its price and pack architecture. Management highlighted that these capabilities should improve decision-making on price/pack combinations, allow faster response to shifts into channels like club, e-commerce, and dollar stores, and support more targeted, strategic price investments when competitiveness demands it. The goal is to protect and grow share while preserving margins through smarter mix and more surgical pricing actions, rather than broad-based hikes that might not fit current consumer value-seeking behavior.

Gross Margin Set to Improve in the Back Half

After margin compression in the first half, Clorox is signaling a more constructive gross margin picture as the year progresses. The company expects Q3 gross margin to be roughly flat year over year, with “solid expansion” in Q4 as temporary ERP-related logistics costs ease and cost-savings programs ramp. Additionally, the termination of the Glad joint venture is forecast to add about 50 basis points of gross margin benefit in the back half. For investors, the story is that near-term margin pressure is largely transitional, with structural savings and mix improvements expected to become more visible by the fourth quarter and into the next fiscal year.

Early Sequential Improvement and January Green Shoots

Despite a tough operating backdrop, Clorox pointed to sequential improvement through Q2 and encouraging early signs in January. The company cited better consumption trends and share gains in the last week of January as indicators that its initiatives may be starting to take hold. Management characterized these as early but meaningful signals of momentum heading into the back half, especially given the combination of heavier innovation, stepped-up marketing, and improved supply-chain stability coming out of ERP implementation.

Disciplined Advertising and Demand Investment

Advertising remains a key lever in Clorox’s plan to support its brands amid weak category growth and heightened competition. The company is targeting ad spend at about 11% of sales for the full year, slightly higher in the first half at around 11.5%. Management emphasized that spending decisions are made at the strategic business unit level, balancing advertising with trade support to back major launches and drive product trial. This disciplined but elevated level of demand investment is intended to keep brands competitive and maximize the payoff from the company’s expanded innovation pipeline.

Weak Category Growth Limits Top-Line Upside

One of the starkest headwinds Clorox faces is sluggish category growth. Core categories were roughly flat in both Q1 and Q2, with Q2 effectively down slightly ex-beauty. Management expects only 0–1% category growth in the back half, well below historical patterns and below what is needed to fully support its long-term Ignite algorithm of 3–5% net sales growth. To deliver that longer-term target, Clorox believes categories would need to recover to roughly 2–2.5% growth, with an additional ~1% coming from professional and international businesses. The subdued category backdrop heightens the importance of share gains, innovation success, and channel execution.

Household Segment Under Pressure From Pricing and Volume

The household segment was a clear soft spot, with Q2 showing both negative pricing and negative volume, even as overall company pricing was essentially flat. Management noted that consumer value-seeking and mix shifts into lower-priced channels are creating an approximate 1 percentage point price/mix headwind for the full year. This is particularly challenging in household categories, where price sensitivity is high and promotional intensity has returned. Clorox will need to offset this drag via innovation-driven mix, efficiencies, and targeted pricing moves, as it can no longer lean on broad price increases to drive the top line.

Share Pressure Amid Elevated Promotions

Clorox acknowledged share losses across parts of its portfolio, highlighting especially intense competition and promotional activity in trash bags and cat litter, including its Glad, Fresh Step, and Scoop Away brands. Promotions in these categories have returned to pre-COVID levels, with pockets of heightened intensity and specific events, such as aggressive Scoop Away promotions at Costco, amplifying noise in the data. This environment forces Clorox to walk a fine line between defending share and protecting margins, particularly when rivals are leaning heavily into discounting and deals.

Supply Chain and Logistics Costs Weigh on Margins

Elevated supply chain and logistics expenses were a notable drag on profitability in Q2, largely tied to ERP stabilization costs and retailer inventory prebuilds. These incremental expenses pushed Q2 EBIT margin down to roughly 5.3%, underscoring how disruptive the transition phase has been. Management expects these costs to decline as systems stabilize and inventory normalizes, with the worst of the ERP-related logistical friction now seen as behind the company. Still, the front-half margin impact has been significant, reinforcing the need for the anticipated back-half recovery to materialize.

Retail Inventory Prebuild Adds Near-Term Noise

Clorox’s final ERP manufacturing phase prompted retailers to prebuild inventory at higher-than-expected levels, which in turn produced a roughly 1-point boost to Q2 shipments. This temporary distortion will reverse in Q3, leading to tougher comparisons and added volatility in reported sales. Management stressed that underlying consumer demand trends are more stable than shipment figures might suggest, but investors should expect some choppiness as these inventory effects wash through the system.

Promotional Tactics and Margin Trade-offs for Share

In the face of aggressive competition, Clorox has selectively deployed price promotions and trade investments in key categories such as trash, litter, and home care to defend and regain market share. While these actions can deliver short-term share stabilization or gains, they come at the cost of near-term margins and a weaker price/mix profile. Management emphasized the need to offset these pressures through innovation, improved efficiency, and RGM capabilities, trying to ensure that promotional spending is strategic and temporary rather than a permanent structural hit to profitability.

Guidance Reaffirmed With Emphasis on Back-Half Margin Rebound

Clorox reaffirmed its full-year guidance, signaling confidence in its back-half plan despite a challenging demand environment. The company expects category growth of 0–1% in the second half after roughly flat results in the first two quarters, with sequential improvement and recent share gains underpinning its outlook. Q2 benefited from about 1 point of shipment favorability tied to ERP prebuilds, which should unwind in Q3, while ERP phasing overall is expected to yield about a 3.5-point sales pickup and roughly $0.90 in EPS benefit in the next fiscal year. Advertising is targeted around 11% of sales for the year, and management anticipates about a 1-point full-year price/mix headwind, reflecting negative pricing in household. With Q2 EBIT margin at 5.3%, Clorox sees Q3 gross margin roughly flat year over year and “solid” expansion in Q4, including about a 50-basis-point benefit from the Glad JV termination and the tapering of ERP/digital adjustments, which should total around $0.08 per share in Q3 before automation and cost-savings benefits build.

In closing, Clorox’s earnings call portrayed a company that has done much of the heavy lifting on systems and strategy but is still wrestling with weak categories, competitive promotions, and household pricing pressure. The path forward hinges on the execution of an ambitious innovation slate, the capture of ERP and cost-savings benefits, and a gradual improvement in category growth. For investors, the story is one of near-term noise and constrained top-line momentum, balanced by the prospect of a cleaner, higher-margin profile and stronger growth as these initiatives and the health & hygiene expansion begin to bear fruit.